SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001615774-18-008816
Filing Date
2018-08-30
Accepted
2018-08-29 21:42:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15356
2 s112351_partiiandiii.htm PART II AND III 954288
3 EXHIBIT 11.1 s112351_ex11-1.htm EX1A-11 CONSENT 3573
4 img001_v1.jpg GRAPHIC 5347
5 img002_v1.jpg GRAPHIC 61528
6 img003_v1.jpg GRAPHIC 70076
7 img004_v1.jpg GRAPHIC 54389
8 img005_v1.jpg GRAPHIC 38143
  Complete submission text file 0001615774-18-008816.txt   1290950
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-10825 | Film No.: 181045461
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1